Home › India's BDR Pharma seeks licence to sell version of Bristol-Myers Squibb cancer drug
 

Keywords :   


India's BDR Pharma seeks licence to sell version of Bristol-Myers Squibb cancer drug

2013-03-18 16:20:28| Biotech - Topix.net

India's BDR Pharmaceuticals International Pvt Ltd has applied to the Indian patents office, seeking permission to sell a generic version of Bristol-Myers Squibb Co's cancer drug, dasatinib, through a so-called compulsory licence mechanism, a BDR executive said on Monday.

Tags: version sell drug cancer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.07Tropical Storm Beryl Public Advisory Number 29A
06.07Summary for Tropical Storm Beryl (AT2/AL022024)
06.07Atlantic Tropical Weather Outlook
06.07Eastern North Pacific Tropical Weather Outlook
05.07Tropical Storm Beryl Potential Storm Surge Flooding Map
05.07Tropical Storm Beryl Probabilistic Storm Surge Graphics
05.07Tropical Storm Beryl Storm Surge Watch/Warning Map
05.07Tropical Storm Beryl Storm Surge Watch/Warning Map
More »